Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2032

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

02

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2032

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

03

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2031

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

04

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 217514

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

05

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-1406

Delist Requested :

Patent Use Description : TREATMENT OF MELANOMA

Patent Expiration Date : 2030-01-20

blank

06

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2296

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

07

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-1406

Delist Requested :

Patent Use Description : TREATMENT OF MELANOMA

Patent Expiration Date : 2030-01-20

blank

08

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2296

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank

09

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

DABRAFENIB MESYLATE

US Patent Number : 8415345

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202806

Patent Use Code : U-2031

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-01-20

blank